^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in both dextrose 5% and sodium chloride 0.9%.

^d Tested in sterile water for injection.

^e Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.

^f Tested in dextrose 5% in sodium chloride 0.9%.

^g Tested in dextrose 5% in sodium chloride 0.225%.

^h Tested in dextrose 5% in Ringer’s injection, dextrose 5% in Ringer’s injection, lactated, dextrose 5%, Ringer’s injection, lactated, and sodium chloride 0.9%.

ⁱ Tested in Ringer’s injection, lactated.

^j Extemporaneously prepared product.

^k Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^l Test performed using the formulation WITHOUT edetate disodium.

^m Tested in dextrose 5% in Ringer’s injection, lactated.

ⁿ Tested in sodium chloride 0.45%.

^o Lyophilized formulation tested.

^p Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^q Injected via Y-site into an administration set running azithromycin.

^r Ampicillin component. Ampicillin in a 2:1 fixed-ratio concentration with sulbactam.

^s Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

^t Trimethoprim component. Trimethoprim in a 1:5 fixed-ratio concentration with sulfamethoxazole.

^u Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^v Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^w Salt not specified.

^x Test performed using the formulation WITH edetate disodium.

^y Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.